Psoriatic arthritis and environment

What the research found.

• One study followed 90189 people with newly recorded psoriasis, and 1409 later had a record of psoriatic arthritis. Against a body mass index below 25, the adjusted odds were 1.79 from 1.46 to 2.19 at 25.0 to 29.9, 2.10 from 1.67 to 2.63 at 30.0 to 34.9, and 2.68 from 2.09 to 3.43 at 35.0 and above.

  Green and colleagues, British Journal of Dermatology, 2020

• One study followed 75395 people with psoriasis for a mean of 5 years, and 976 developed psoriatic arthritis. That's 26.5 cases per 10000 person-years. Against a body mass index below 25, the relative risks were 1.09 from 0.93 to 1.28, then 1.22 from 1.02 to 1.47, then 1.48 from 1.20 to 1.81.

  Love and colleagues, Annals of the Rheumatic Diseases, 2012

• One study of 21429 people with psoriatic arthritis looked at where they lived. High social deprivation reached 25.7 percent among Black patients, against 2.3 percent Asian, 12.5 percent White, and 17.3 percent other. High disease activity followed the same order, at 40.2 percent against 25.8, 29.6, and 33.5 percent.

  Dowell and colleagues, Arthritis and Rheumatology, 2026

• One study of 960 people with psoriatic arthritis found 166 who had failed four or more advanced drugs. Four things went with that after adjustment: female sex at an odds ratio of 2.3 from 1.4 to 3.8, axial disease at 2.1 from 1.2 to 3.6, depression at 2.0 from 1.1 to 3.7, and obesity at 1.7 from 1.0 to 2.8.

  Haberman and colleagues, Arthritis Research and Therapy, 2025

• One genetic study tested vitamin D against several autoimmune diseases. Higher genetically predicted vitamin D went with lower odds of psoriasis, at 0.91 from 0.85 to 0.97 per 10 ng/ml. It found nothing for the autoimmunity group as a whole, at 0.99 from 0.95 to 1.03.

  Zhao and colleagues, Seminars in Arthritis and Rheumatism, 2023

Body weight, in two large studies

Two studies followed people who had psoriasis and watched who went on to develop psoriatic arthritis. Between them they covered more than 165000 people. Both asked the same question about body weight.

The first followed 90189 people with newly recorded psoriasis. Over the study, 1409 of them had a record of psoriatic arthritis. It sorted them into weight bands and compared each against a body mass index below 25.

The odds rose with each band. At 25.0 to 29.9 the adjusted odds ratio was 1.79, from 1.46 to 2.19. At 30.0 to 34.9 it was 2.10, from 1.67 to 2.63. At 35.0 and above it was 2.68, from 2.09 to 3.43.

The second study followed 75395 people with psoriasis for a mean of 5 years. Of those, 976 developed psoriatic arthritis, which is 26.5 cases per 10000 person-years. It used the same weight bands.

Its numbers were much smaller. The relative risks were 1.09, from 0.93 to 1.28. Then 1.22, from 1.02 to 1.47. Then 1.48, from 1.20 to 1.81. The lowest band crosses 1, so it isn't significant.

What to make of two answers that far apart

A reader could take the larger set and say the risk nearly triples. A reader could take the smaller set and say it rises by about half. Both would be quoting a real study.

The honest position is that the size is unsettled. These two studies used different populations, different follow-up, and different adjustments. This page can't say which is closer to the truth.

What they agree on is the form of it. In both, the risk rose in step as weight rose, across three bands, with no reversal. That rising line is one of the better signs that a link is real rather than an accident of one dataset.

So the direction is worth taking seriously. The multiplier itself isn't worth memorizing. Anybody quoting you one without the other is quoting half the evidence.

What neither study tested

Neither study assigned anybody a weight. Both measured what people already weighed and followed them. That single fact decides what the figures can mean.

The larger study did report one thing pointing forward. It looked at what happened when weight changed. A body mass index that fell year on year over a 10-year period went with lower risk than one staying constant.

That's a useful observation and it isn't a trial. People whose weight falls over ten years differ from people whose weight doesn't. They differ in health, in circumstances, and in much else the study can't fully adjust for.

So this page won't tell you that losing weight prevents psoriatic arthritis. It will say the evidence points that way and hasn't been tested. Your team is the right person to take that to.

Weight after the diagnosis

One study asked a different question. It looked at 960 people who already had psoriatic arthritis. Of those, 166 had failed four or more biologic or targeted drugs.

Four things went with that after adjustment. Female sex came out at an odds ratio of 2.3, from 1.4 to 3.8. Axial disease came out at 2.1, from 1.2 to 3.6. Depression came out at 2.0, from 1.1 to 3.7. And obesity came out at 1.7, from 1.0 to 2.8.

Read that last interval carefully. Its lower bound sits right on 1.0, which makes it the weakest of the four. The finding is real enough to report and fragile enough to hold loosely.

What's useful about it is the company it keeps. Depression appears in that list beside obesity. Both are things a treatment plan can address rather than things a patient simply has.

Where you live

One study of 21429 people with psoriatic arthritis asked about their neighborhoods. It's the only source on this page about the environment in that wider sense. It's also the largest study here.

High social deprivation was unevenly spread. It reached 25.7 percent among Black patients. It was 17.3 percent among other groups, 12.5 percent among White patients, and 2.3 percent among Asian patients.

High disease activity followed the same order. It reached 40.2 percent among Black patients and 33.5 percent in other groups. It was 29.6 percent among White patients and 25.8 percent among Asian patients.

About 7 percent of the patients lived in districts carrying a historical grading from the last century. That grading was applied long before any of them were ill. Smoking, obesity, high social deprivation, federal insurance, and high disease activity were all commoner in districts historically graded hazardous.

This page reports those figures and offers no explanation for them. The study's abstract gives none. What they do show is that the environment in this disease isn't only about chemicals and dust.

Vitamin D

One genetic study tested vitamin D against a list of autoimmune diseases. It used genetic variants that predict blood levels. Nobody's level was measured directly.

Higher predicted vitamin D went with lower odds of psoriasis. The odds ratio was 0.91 per 10 ng/ml, from 0.85 to 0.97. That result replicated in independent data.

It found nothing for the autoimmunity group as a whole. That came out at 0.99, from 0.95 to 1.03. The interval sits squarely across 1.

So there's a signal in the skin disease and none in the wider group. Psoriatic arthritis wasn't reported separately. This page gives no vitamin D target and no dose, and nothing here is a reason to start taking one.

What none of this tested

Every study on this page measured something people already had. Not one assigned a weight, a neighborhood, or a vitamin. Not one removed anything and watched what happened.

So each of these findings is a link rather than a cause. A link is a reason to look further and a reason to raise something with your team. It isn't proof that changing the thing changes the disease.

The one partial exception is the falling body mass index finding. It's still an observation. It describes what happened to people who lost weight rather than what happens when somebody does.

Tell your team what applies to you. Ask what it means for your own plan. That's what these figures are genuinely good for, and it's more than most environmental evidence on this site supports.

Common misconceptions.

Cautions specific to this condition.

• Ask your team what your own weight means for your treatment rather than taking a figure from this page. One study found obesity going with failure of four or more advanced drugs, at 1.7 from 1.0 to 2.8.
• Read a rising series of odds ratios as a stronger signal than a single number. Both weight studies here rose in step across three bands.
• Don't read either weight study as showing that losing weight prevents arthritis. Neither assigned anybody a weight or removed one.
• Mention smoking and where you live if they apply. One study found both travelling with higher disease activity across 21429 people.
• This page gives no diet, no weight target, and no vitamin D dose. Nothing here has been tested by changing what anybody did.
• Treat the difference between 2.68 and 1.48 as real uncertainty. Two large studies of the same question got answers that far apart.

Questions patients ask.